Department of Psychiatry, University of Manitoba, 771 Bannatyne Ave, Winnipeg, Manitoba, R3E 3N4, Canada.
Manitoba Centre for Health Policy, Department of Community Health Sciences, University of Manitoba, 408 - 727 McDermot Ave, Winnipeg, Manitoba, R3E 3P5, Canada.
J Psychiatr Res. 2019 Jul;114:105-112. doi: 10.1016/j.jpsychires.2019.04.019. Epub 2019 Apr 22.
A significant minority of unspecified psychosis presentations progress to schizophrenia. Clinical risk factors can inform targeted referral to specialized treatment programs, but few population studies have examined this. In this study, we used health administrative data for a population-based cohort from Manitoba, Canada to characterize the risk and identify vulnerable subgroups for a future diagnosis of schizophrenia after a diagnosis of unspecified psychotic disorder. Individuals aged 13-60 years with an inpatient or outpatient diagnosis of unspecified psychotic disorder between April 1, 2007 and March 31, 2012, and without any prior diagnosis of schizophrenia or related disorder, were identified (N = 3, 289). The primary outcome was a diagnosis of schizophrenia recorded after the index diagnosis of unspecified psychotic disorder and before March 31, 2015. Adjusted hazard ratios were computed controlling for age, sex, urbanicity, income, prior diagnosis of unspecified psychotic disorder, provider making the diagnosis, prior 12-month psychiatric hospitalization, and prior 12-month diagnoses of mood, anxiety, substance use, or personality disorders, and substance-induced psychosis. A classification tree identified vulnerable subgroups. The cumulative risk of a future diagnosis of schizophrenia was 26% during the follow-up period (mean 4.5 years), with a mean time to diagnosis of 2.0 years. The most vulnerable subgroup was diagnosed by a psychiatrist, younger than 27 years, without a mood or anxiety disorder, male, and residing in a low-income neighborhood; the rate of a subsequent schizophrenia diagnosis was 61.2%. These results support that identification of specific sociodemographic and clinical factors can help clinicians counsel and intervene with those at highest risk.
一小部分未特定的精神病发作会发展为精神分裂症。临床风险因素可以为有针对性地转介到专门的治疗计划提供信息,但很少有人群研究对此进行了研究。在这项研究中,我们使用了加拿大马尼托巴省的人群队列的健康管理数据,以描述风险,并确定在未特定的精神病性障碍诊断后未来诊断为精神分裂症的脆弱亚组。在 2007 年 4 月 1 日至 2012 年 3 月 31 日期间,有门诊或住院诊断为未特定的精神病性障碍且无任何先前诊断为精神分裂症或相关障碍的 13-60 岁个体(N=3289)被确定为研究对象。主要结局是在未特定的精神病性障碍诊断后且在 2015 年 3 月 31 日之前记录的精神分裂症诊断。通过控制年龄、性别、城市人口、收入、未特定的精神病性障碍的先前诊断、做出诊断的医生、过去 12 个月的精神病住院治疗以及过去 12 个月的情绪、焦虑、物质使用或人格障碍以及物质引起的精神病的诊断,计算了调整后的危险比。分类树确定了脆弱亚组。在随访期间(平均 4.5 年),未来诊断为精神分裂症的累积风险为 26%,平均诊断时间为 2.0 年。最脆弱的亚组是由精神科医生诊断的,年龄小于 27 岁,没有情绪或焦虑障碍,男性,居住在低收入社区;随后诊断为精神分裂症的比例为 61.2%。这些结果支持识别特定的社会人口和临床因素可以帮助临床医生对风险最高的患者进行咨询和干预。